Enhanced natriuretic response to neutral endopeptidase inhibition in heart-transplant recipients.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  HYPERTENSION

• Publication date

  1999-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.33.4.969PMID 10205232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelin participates in increased circulating atrial natriuretic peptide early after human heart transplantation.

  1998cited by this paper
• Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients.

  1997cited by this paper
• Enhanced natriuretic response to neutral endopeptidase inhibition in patients with moderate chronic renal failure.

  1997cited by this paper
• Breakdown of blood pressure and body fluid homeostasis in heart transplant recipients.

  1996cited by this paper
• Renal response to candoxatrilat in patients with heart failure.

  1995cited by this paper
• The role of neutral endopeptidase in dogs with evolving congestive heart failure.

  1995cited by this paper
• Hormonal and renal responses to neutral endopeptidase inhibition in normal humans on a low and on a high sodium intake

  1995cited by this paper
• Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension

  1995cited by this paper
• Acute renal effects of neutral endopeptidase inhibition in humans.

  1994cited by this paper
• Blood pressure and endocrine responses to changes in dietary sodium intake in cardiac transplant recipients. Implications for the control of sodium balance.

  1994cited by this paper
• Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients.

  1994cited by this paper
• Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension.

  1993cited by this paper
• Renal, hemodynamic and neurohormonal effects of atrial natriuretic factor in cardiac allograft recipients treated with cyclosporin A.

  1993cited by this paper
• Role of cardiac innervation in atrial natriuretic peptide secretion in transplanted heart recipients.

  1993cited by this paper
• Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.

  1993cited by this paper
• Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.

  1992cited by this paper
• Effect of pharmacological manipulation of endogenous atriopeptin activity on renal function.

  1992cited by this paper
• Selective downregulation of rat renal clearance receptors for atrial natriuretic peptide by chronic high-salt intake: study on isolated membranes using 125I-labelled c-atrial natriuretic peptide-(4-23).

  1992cited by this paper
• Neurohormonal Inhibition and Hemodynamic Unloading During Prolonged Inhibition of ANF Degradation in Patients With Severe Chronic Heart Failure

  1992cited by this paper
• Level and diurnal variations of hormones of interest to the cardiovascular system in patients with heart transplants.

  1992cited by this paper
• Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism.

  1992cited by this paper
• ANF-mediated renal cGMP generation in congestive heart failure.

  1991cited by this paper
• Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.

  1991cited by this paper
• Role of Endogenous Atrial Natriuretic Peptide in Regulating Sodium Excretion in Spontaneously Hypertensive Rats: Effects of Neutral Endopeptidase Inhibition

  1991cited by this paper
• Dietary Sodium and Inhibition of Neutral Endopeptidase 24.11 in Essential Hypertension

  1991cited by this paper
• Rapid reduction but lack of normalization of atrial natriuretic peptide levels in patients with congestive heart failure after cardiac transplantation.

  1991cited by this paper
• Long-term regulation of Na(+)-H+ exchange in vascular smooth muscle cells: role of protein kinase C.

  1991cited by this paper
• Diverse biological actions of atrial natriuretic peptide.

  1990cited by this paper
• Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure.

  1990cited by this paper
• The hydrolysis of brain and atrial natriuretic peptides by porcine choroid plexus is attributable to endopeptidase-24.11.

  1990cited by this paper
• Antihypertensive activity of sinorphan.

  1990cited by this paper
• The atriopeptidase inhibitor UK 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans.

  1990cited by this paper
• Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.

  1990cited by this paper
• Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effects.

  1990cited by this paper
• Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.

  1989cited by this paper
• Role of cardiac atria in the human renal response to changing plasma volume.

  1988cited by this paper
• Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor.

  1988cited by this paper
• The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11.

  1987cited by this paper
• Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis.

  1986cited by this paper
• Fluid conservation in athletes: responses to water intake, supine posture, and immersion.

  1986cited by this paper
• Influence of age on the cardiovascular and renal responses to tilting.

  1966cited by this paper

• Noninvasive Biomarkers for Cardiac Allograft Rejection Monitoring: Advances, Challenges, and Future Directions

  2026cites this paper
• Novel Drugs for Hypertension and Heart Failure: Struggling for a Place Under the Sun.

  2017cites this paper
• Brain natriuretic peptide and right heart dysfunction after heart transplantation

  2017cites this paper
• Angiotensin‐converting enzyme inhibition prevents myocardial infarction‐induced increase in renal cortical cGMP and cAMP phosphodiesterase activities

  2015cites this paper
• Fonction endocrine du cœur

  2015cites this paper
• Current role of neprilysin inhibitors in hypertension and heart failure.

  2014cites this paper
• Pretreatment with brain natriuretic peptide reduces skeletal muscle mitochondrial dysfunction and oxidative stress after ischemia-reperfusion.

  2013cites this paper
• stress after ischemia-reperfusion skeletal muscle mitochondrial dysfunction and oxidative Pretreatment with brain natriuretic peptide reduces

  2013cites this paper
• Mechanisms involved in increased plasma brain natriuretic peptide after heart transplantation.

  2011influential citation
• Endocrine heart after lung transplantation: increased brain natriuretic peptide is related to right ventricular function

  2010cites this paper
• Does circulating BNP normalize after heart transplantation in patients with normal hemodynamic and right and left heart functions?

  2008cites this paper
• Prognostic value of brain natriuretic peptide in heart transplant patients.

  2007cites this paper
• Renal hyporesponsiveness to brain natriuretic peptide: both generation and renal activity of cGMP are decreased in patients with pulmonary hypertension.

  2006cites this paper
• The Therapeutic Potential of Candoxatril, a Neutral Endopeptidase Inhibitor, in Humans

  2006cites this paper
• B-type natriuretic peptide as a marker of allograft rejection after heart transplantation.

  2005cites this paper
• Perioperativer Verlauf von BNP (brain natriuretic peptide) nach aortokoronarer Bypassoperation bei Patienten mit präoperativ reduzierter LV-Funktion

  2003cites this paper
• Radioimmunometric assay of B‐type natriuretic peptide (BNP) in heart transplantation: correlation between BNP determinations and biopsy grading of rejection

  2003cites this paper
• Mechanisms of renal hyporesponsiveness to ANP in heart failure

  2003cites this paper
• Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients.

  2002cites this paper
• Role of cardiac‐renal neural reflex in regulating sodium excretion during water immersion in conscious dogs

  2002cites this paper
• ENDOPEPTIDASE INHIBITION IN CHRONIC, STABLE HEART-TRANSPLANT PATIENTS

  2002cites this paper
• Cardiac natriuretic peptides during exercise and training after heart transplantation.

  2001cites this paper
• Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use.

  2001cites this paper
• Lack of acute cyclosporine nephrotoxicity in late heart-transplant recipients.

  2000cites this paper
• Exercise-induced increase in circulating adrenomedullin is related to mean blood pressure in heart transplant recipients.

  2000cites this paper
• Hypertension in heart transplantation

  1999cites this paper